INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol

BACKGROUND: The course of Alzheimer’s disease (AD) includes a 10–20-year preclinical period with progressive accumulation of amyloid β (Aβ) plaques and neurofibrillary tangles in the absence of symptomatic cognitive or functional decline. The duration of this preclinical stage in part depends on the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Trials
Glavni autori: Moga, Daniela C., Beech, Brooke F., Abner, Erin L., Schmitt, Frederick A., El Khouli, Riham H., Martinez, Ashley I., Eckmann, Lynne, Huffmyer, Mark, George, Rosmy, Jicha, Gregory A.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937673/
https://ncbi.nlm.nih.gov/pubmed/31888732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3993-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items